L. Simonsen et al., Effect of rotavirus vaccination programme on trends in admission of infants to hospital for intussusception, LANCET, 358(9289), 2001, pp. 1224-1229
Citations number
20
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Background Studies have reported a temporal association between a first dos
e of rotavirus vaccine (Rotashield) and infant intussusception. We investig
ated the effect of Rotashield vaccination use on intussusception admissions
in ten US states.
Methods We analysed electronic databases containing 100% hospital discharge
records for 1993-99 from ten US states, where an estimated 28% of the birt
h cohort had received Rotashield (based on manufacturer's net sales data).
We examined records of infants admitted to hospital (<365 days old) with an
y mention of intussusception (international Classification of Diseases, nin
th revision. clinical modification code 560.0). Excess admissions for intus
susception during the period of Rotashield availability (October 1998 to Ju
ne 1999) were estimated by direct comparison with the corresponding period
of October 1997 to June 1998 (before Rotashield was available) and with adj
ustment for secular trends during 1993-98 by Poisson regression.
Findings Hospital admission for intussusception among infants younger than
365 days of age during the Rotashield period compared with previously was 4
% lower (10 cases) by direct comparison and 10% lower (27 cases) by trend c
omparison, corresponding to a negative population attributable risk. Among
infants aged 45-210 days (target age range for a first Rotashield dose), we
estimated an increase in intussusception admissions of 1% (one excess admi
ssion) by direct comparison and 4% (4.6 excess admissions) by trend compari
son, corresponding to a population attributable risk range of one excess ad
mission in 66 000-302 000.
Interpretation We found no evidence of increased infant intussusception adm
issions during the period of Rotashield availability. The total intussuscep
tion admission risk attributable to Rotashield was substantially lower than
previous estimates based on studies focusing on the immediate postvaccinat
ion weeks.